| Smiles |
O=C(OC5(=C(OC2(=CC(OC(=O)C)=C(OC1(=CC(OC(=O)C)=C(OC(=O)C)C(=C1)OC(=O)C))C(=C2)OC(=O)C))C(OC4(=C(OC(=O)C)C=C(OC3(=C(OC(=O)C)C=C(OC(=O)C)C=C3OC(=O)C))C=C4OC(=O)C))=CC(=C5OC(=O)C)OC(=O)C))C
|
| CAS number |
61470-22-2
|
| Polar Surface Area |
378,82
|
| calculated LogS |
-14,704
|
| Molweight |
1200,97
|
| calculated LogP |
7,0691
|
| H-Acceptors |
30
|
| H-Donors |
0
|
| Ro5 violations |
3
|
| Druglikeness |
-2,1022
|
| DrugScore |
0,0616789
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
low
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
-0,1645
|
| Rat Acute Toxicity |
2,3075
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2+
|
| Caco-2 Permeability2 |
0,8663
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,6853
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB+
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
High HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
61470-22-2
|
